The use of statins in acute myeloid leukemia
PhD ceremony: Ms. K. van der Weide, 14.45 uur, Aula Academiegebouw, Broerstraat 5, Groningen
Dissertation: The use of statins in acute myeloid leukemia
Promotor(s): prof. E. Vellenga, prof. E.G.E. de Vries en prof. F. Kuipers
Faculty: Medical Sciences
Patients with acute myeloid leukemia (AML) display a dysfunctional cholesterol metabolism in their bone marrow cells, as well as increased cholesterol levels in these AML cells upon in vitro exposure to chemotherapy. This is expected to protect the cells from cytotoxic treatment effects. Intervention with this protective pathway is therefore a potential attractive means to improve therapeutic outcome. Statins inhibit cholesterol synthesis by blocking HMG-CoA reductase, the rate-controlling enzyme of the mevalonate pathway. We showed that combining statins with standard chemotherapy or a farnesyltransferase inhibitor induces more cytotoxicity in AML bone marrow samples than the separate compounds. However, a subset of patient samples appeared to be relatively resistant to statin treatment. To distinguish sensitive from insensitive patients, cell lines with different sensitivities were investigated. It appeared that the differences in response to statins are due to differential effects on the isoprenylation route, rather than the cholesterol synthesis route, of the mevalonate pathway. Summarizing, we demonstrated heterogeneity in the effects of statins in AML cells and patients. Also, we may be able to identify AML patients that will most likely benefit from (combination) treatment with statins.
Last modified: | 13 March 2020 01.10 a.m. |
More news
-
06 June 2025
India-Netherlands Hydrogen Valley Fellowship Programme announced
To coincide with World Environment Day, 5 June 2025, the Indian Department of Science and Technology and the University of Groningen yesterday announced a Hydrogen Valley Fellowship Programme Partnership, allowing talented Indian scholars working on...
-
28 May 2025
Gaan avondmensen cognitief sneller achteruit dan ochtendmensen?
Wie ’s avonds opleeft en laat naar bed gaat, heeft een grotere kans op cognitieve achteruitgang dan een ochtendmens, blijkt uit UMCG-onderzoek.
-
27 May 2025
An adventure in the brain
In the exhibition Brainstorm in the University Mueseum, Iris Sommer and two other brain researchers from Groningen explain the gut-brain connection, how it was discovered that the brain does what it does, and how games motivate you to perform...